Gradually expand drug therapy!

Chronic heart failure mainly occurs in older people. The drug therapy options available today represent a decisive advance in treatment options. According to current ESC guideline recommendations, it is advisable to implement the “Fantastic Four” (beta-blockers, SGLT-2-i, ACE-i or ARNI and MRA) quickly, as this is associated with a survival benefit, can slow down the progression of heart failure and help patients to achieve a better quality of life.